Mechanism of Action
Like other sulfonamides, Sulfadimethoxinum disrupts metabolic processes in bacterial cells via competitive antagonism with para-aminobenzoic acid (PABA). This blocks the synthesis of dihydropteroic acid, which is essential for bacterial replication.
Pharmacokinetics and Classification
The drug is well absorbed from the gastrointestinal tract, providing a systemic effect. Due to its elimination half-life ($t_{1/2}$ of 24–48 hours), Sulfadimethoxine is classified as a long-acting sulfonamide (alongside sulfamonomethoxine and sulfamethoxypyridazine). Because of these pharmacokinetic properties, it is administered less frequently—once to twice daily.
Indications
The drug is used for infectious and inflammatory conditions caused by susceptible organisms. In clinical practice and pharmacology courses, it is studied as a systemic antimicrobial agent. Administration route: oral, 0.5–1.0 g once daily.
Clinical Administration and Formulations
In pharmacopeias, the drug is available as a powder and in 0.2 g and 0.5 g tablets. Prescribers account for its pharmacokinetic profile: slow elimination ($t_{1/2}$ of 24–48 hours) maintains stable therapeutic blood concentrations with a once-daily dosing regimen (up to twice daily in specific protocols).